Thromboxane receptor
| Thromboxane receptor | |||||||
|---|---|---|---|---|---|---|---|
| Identifiers | |||||||
| Symbol | TBXA2R | ||||||
| NCBI gene | 6915 | ||||||
| HGNC | 11848 | ||||||
| OMIM | 188070 | ||||||
| RefSeq | NM_001062 | ||||||
| UniProt | P21731 | ||||||
| Other data | |||||||
| Locus | Chr. 19 p13.3 | ||||||
| |||||||
The thromboxane receptor is a protein that in humans is encoded by the TBXA2R gene. This receptor is a member of the G protein-coupled receptor superfamily and is specifically responsive to thromboxane A2, a potent mediator of platelet aggregation and vasoconstriction. The receptor plays a crucial role in the pathophysiology of several cardiovascular diseases, including stroke, myocardial infarction, and hypertension.
Function[edit | edit source]
The thromboxane receptor mediates the action of thromboxane A2, which is produced by the enzyme thromboxane-A synthase from prostaglandin H2. Binding of thromboxane A2 to this receptor induces various responses including platelet aggregation, vasoconstriction, and proliferation of vascular smooth muscle cells, contributing to the formation of atherosclerotic plaques and cardiovascular disease.
Gene[edit | edit source]
The TBXA2R gene is located on the short arm of chromosome 19 (19p13.3) in humans. It encodes a protein of 343 amino acids which is widely expressed in various tissues, including the lung, liver, and spleen, with particularly high expression in platelets.
Clinical Significance[edit | edit source]
Alterations in the expression or function of the thromboxane receptor have been implicated in a variety of clinical conditions. Antagonists of this receptor are being studied for their potential benefits in treating cardiovascular diseases by reducing thrombotic events. Additionally, genetic polymorphisms in TBXA2R have been associated with an increased risk of myocardial infarction and stroke in certain populations.
Pharmacology[edit | edit source]
Several thromboxane receptor antagonists have been developed to inhibit the effects of thromboxane A2. These antagonists are being investigated for their therapeutic potential in reducing the risk of thrombosis and its complications in cardiovascular diseases.
See also[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
